Seligson & Co Rahastoyhtiö Oyj
25.3.2021 15:31:33 CET | Globenewswire | Press release
Seligson & Co Fund Management Company Plc
STOCK EXCHANGE NOTICE 25 March 2021
SELIGSON & CO OMX HELSINKI 25 EXCHANGE TRADED FUND UCITS ETF: ANNUAL REPORT, BOARD OF THE MANAGEMENT COMPANY AND AUDITOR
The Annual Report of Seligson & Co OMX Helsinki 25 Exchange Traded Fund UCITS ETF, dated 31 December 2020, has been published. The report, which is in Finnish, forms part (pages 24 to 27) of the attached common Annual Report for all the funds managed by Seligson & Co Fund Management Company. The report includes the Auditor's Report, and it is also available at www.seligson.fi/sco/suomi/esitteet/.
The following members were elected to the board of Seligson & Co Fund Management Company Plc at the Annual General Meeting held on 25 March 2021: Samu Anttila, Jarkko Niemi and Mikko Vasko. KPMG Plc was chosen as the auditor and CPA Marcus Tötterman as the deputy auditor.
Further information:
Mari Rautanen
email: mari.rautanen@seligson.fi
Phone +358 (0)9 6817 8224
Seligson & Co Fund Management Company Plc
Ari Kaaro
Managing Director
email: ari.kaaro@seligson.fi
Phone +358 (0)9 6817 8217
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S13.6.2026 18:45:00 CEST | Press release
Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
King Faisal Specialist Hospital & Research Centre13.6.2026 15:57:00 CEST | Press release
KFSH Showcases Trusted AI as the Foundation for Scalable Healthcare Transformation at HLTH Europe 2026
Chery Group13.6.2026 11:39:45 CEST | Press release
FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch
Hotel Belles Rives13.6.2026 00:11:17 CEST | Press release
Julian Barnes Named Laureate of the 2026 Fitzgerald Prize
Sanofi Winthrop Industrie13.6.2026 00:09:43 CEST | Press release
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
